![Marc Bozec](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Bozec
Amministratore Delegato presso
OSE IMMUNOTHERAPEUTICS
Profilo
Marc Le Bozec is the founder of BioProtein Technologies SA, founded in 1998.
Mr. Bozec is currently the Chief Executive Officer at OSE Immunotherapeutics SA since 2025 and an Independent Director at Nicox SA since 2024.
Formerly, Director at CYTOO SA from 2013 to 2015.
Education includes an undergraduate degree from École des Hautes Études Commerciales de Paris.
Posizioni attive di Marc Bozec
| Società | Posizione | Inizio |
|---|---|---|
| NICOX SA | Direttore/Membro del Consiglio | 16/07/2024 |
| OSE IMMUNOTHERAPEUTICS | Amministratore Delegato | 02/10/2025 |
Precedenti posizioni note di Marc Bozec
| Società | Posizione | Fine |
|---|---|---|
CYTOO SA
 CYTOO SA Medical SpecialtiesHealth Technology Operates as a contract research organization which develops physiological cell-based assays | Direttore/Membro del Consiglio | 01/01/2015 |
BioProtein Technologies SA
 BioProtein Technologies SA BiotechnologyHealth Technology Develops recombinant therapeutic proteins and vaccines | Fondatore | - |
Formazione di Marc Bozec
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
10
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Nicox SA
 Nicox SA Pharmaceuticals: MajorHealth Technology Manufactures and sells ophthalmology biopharmaceuticals | Health Technology |
BioProtein Technologies SA
BioProtein Technologies SA BiotechnologyHealth Technology Develops recombinant therapeutic proteins and vaccines | Health Technology |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology Operates as a contract research organization which develops physiological cell-based assays | Health Technology |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
